Advertisement
MEDX vs XLV
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDX is a Buy and XLV is a Buy.
MEDX in upward trend: 10-day moving average crossed above 50-day moving average on October 23, 2026
The 10-day moving average for MEDX crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on MEDX as a result. In 52 of 61 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for MEDX just turned positive on October 12, 2026. Looking at past instances where MEDX's MACD turned positive, the stock continued to rise in 26 of 32 cases over the following month. The odds of a continued upward trend are 81%.
MEDX moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where MEDX advanced for three days, in 181 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 162 of 189 cases where MEDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
Bearish Trend Analysis
The 10-day RSI Indicator for MEDX moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 21 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 54 cases where MEDX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MEDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
MEDX broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
XLV's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for XLV turned positive on October 09, 2026. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in 42 of 48 cases over the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on XLV as a result. In 82 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
XLV moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for XLV crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.
Following a +2.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in 263 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 230 of 271 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
Bearish Trend Analysis
The 10-day RSI Indicator for XLV moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 27 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 67 cases where XLV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
XLV broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| MEDX | XLV | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 84% | 2 days ago 73% |
| Stochastic ODDS (%) | 2 days ago 67% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 85% |
| MACD ODDS (%) | 2 days ago 81% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 84% |
| Advances ODDS (%) | 3 days ago 82% | 2 days ago 81% |
| Declines ODDS (%) | 9 days ago 73% | 6 days ago 81% |
| BollingerBands ODDS (%) | 2 days ago 88% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 86% | 2 days ago 85% |
Advertisement
MEDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, MEDX has been loosely correlated with OGN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if MEDX jumps, then OGN could also see price increases.
| Ticker / NAME | Correlation To MEDX | 1D Price Change % | ||
|---|---|---|---|---|
| MEDX | 100% | -0.30% | ||
| OGN - MEDX | 43% Loosely correlated | +0.29% | ||
| SNY - MEDX | 40% Loosely correlated | +0.23% | ||
| MRK - MEDX | 36% Loosely correlated | -0.48% | ||
| GILD - MEDX | 34% Loosely correlated | +0.92% | ||
| BIIB - MEDX | 32% Poorly correlated | -0.64% | ||
More | ||||
XLV and
Correlation & Price change
A.I.dvisor indicates that over the last year, XLV has been closely correlated with LLY. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then LLY could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NBET | 40.01 | 0.50 | +1.26% |
| Neuberger Energy Transition & Infrastructure ETF (NBET) | |||
| RSPM | 40.33 | -0.01 | -0.04% |
| Invesco S&P 500 Equal Weight Materials ETF (RSPM) | |||
| BBUS | 135.14 | -0.47 | -0.35% |
| JPMorgan BetaBuilders U.S. Equity ETF (BBUS) | |||
| QDEC | 35.40 | -0.17 | -0.47% |
| FT Vest Nasdaq-100 Buffer ETF - December (QDEC) | |||
| HVAC | 29.01 | -0.31 | -1.06% |
| Advisorshares HVAC And Industrials ETF | |||